Medication info
Rosuvastatin and Amlodipine Tablets 10/10 mg

Rosuvastatin and Amlodipine Tablets 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletAmlodipine Besylate›13.889mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pale orange round film-coated tablet
Packaging
30 tablets / bottle
Approval status
Active

MFDS item code 201901087 · Approved 2019.02.21 · Insurance code 642105400

Summary

Main use
Treatment of dyslipidemia, hypertension, and angina; inhibition of atherosclerosis progression; prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and rosuvastatin. ○ Amlodipine Adults: Administer 5mg of amlodipine orally once daily. The dose may be increased to a maximum of 10 mg daily according to the patient's response. Adjust the dose as appropriate according to symptoms. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate according to LDL cholesterol levels, treatment goals, and the patient's response, at intervals of 4 weeks or longer; the dose may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients. Patients taking amlodipine and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of dyslipidemia, hypertension, and angina; inhibition of atherosclerosis progression; prevention of cardiovascular disease

  • Hypertension
  • fixed closure of coronary arteries
  • coronary vasospasm
  • vasoconstriction
  • myocardial ischemia
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein
View approved original text

This medication is used for patients who require simultaneous treatment with both amlodipine and rosuvastatin. Amlodipine treats hypertension and myocardial ischemia caused by stable and variant angina, reducing the risk of hospitalization due to angina and coronary artery revascularization. Rosuvastatin is used as an adjunct in cases of hypercholesterolemia and familial hypercholesterolemia where dietary control is difficult. Additionally, it helps to delay the progression of atherosclerosis in patients with hypercholesterolemia and reduces the risk of stroke, myocardial infarction, and revascularization in patients at high risk for cardiovascular disease. Therefore, this medication is used to manage hypertension, angina, and the combined risks of hyperlipidemia and cardiovascular disease.

How to take

Adult dose

This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and rosuvastatin. ○ Amlodipine Adults: Administer 5mg of amlodipine orally once daily. The dose may be increased to a maximum of 10 mg daily according to the patient's response. Adjust the dose as appropriate according to symptoms. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate according to LDL cholesterol levels, treatment goals, and the patient's response, at intervals of 4 weeks or longer; the dose may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients. Patients taking amlodipine and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication should not be used in patients with allergies to any of its specific components. Pregnant or potentially pregnant women and nursing mothers should not take this medication, and effective contraception should be used if treatment is necessary. Patients with severe liver dysfunction or active liver disease should not take this medication either. Caution is also required in patients with severe aortic stenosis, those in shock, or with muscle diseases. Furthermore, it is prohibited for patients on specific immunosuppressants or those with severe kidney failure. Patients with a history of muscle disorders, alcoholism, hypothyroidism, etc., should be particularly cautious with high doses. Severe hypotension patients, dialysis patients, elderly patients, and those with severe muscle weakness should use this medication with caution. Patients with a history of liver disease or excessive alcohol consumption should have regular liver function tests. If symptoms related to muscle such as muscle pain, weakness, or cramps occur, consult a doctor immediately, and discontinuation and blood testing may be necessary. Caution is required during testing as muscle enzymes may elevate due to exercises or other reasons. This medication may rarely cause side effects such as headaches, dizziness, constipation, muscle pain, and swelling. Discontinuation of the drug and consultation with medical professionals is required if severe skin rashes or allergic reactions occur. This medication can interact with other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Particular caution is required when taking it with specific antibiotics, immunosuppressants, and fibrate drugs. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use effective contraception during treatment. Safety in children has not been established, so it should not be used in pediatric patients. In cases of overdose, symptoms such as severe hypotension, increased heart rate, and shock may occur, requiring immediate medical attention and appropriate emergency treatment. This medication should be kept out of reach of children and stored in its original container to prevent misuse and deterioration of quality.

Side effects

Headache, dizziness, peripheral edema, chest pain, wrist fracture, gout, dysuria, constipation, dental fracture, weakness, myalgia, myopathy, rhabdomyolysis, angioedema, hypersensitivity reaction, diabetes, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myositis, thrombocytopenia, jaundice, hepatitis, elevation of liver enzymes, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, acute renal failure, oliguria, elevated serum creatinine, increased ALT, increased CK, increased AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly closed container. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius. This way, the efficacy of the medication can be preserved for a long time.

Appearance and packaging

Appearance

Pale orange round film-coated tablet

Package unit

30 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.